Impact BioMedical, Inc. (IBO) — Financial Flexibility Index
Impact BioMedical, Inc. (IBO) has a Financial Flexibility Index of -0.07x as of September 2025. Free cash flow of $-1.99 Million (operating CF $-1.99 Million minus capex $0.00) represents 0% of total liabilities ($27.06 Million). Also explore how fast is Impact BioMedical, Inc. growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Impact BioMedical, Inc. Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Impact BioMedical, Inc. across 8 annual periods. Check how strategically is Impact BioMedical, Inc.'s equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Impact BioMedical, Inc. (2017–2024)
Year-by-year free cash flow to debt coverage for Impact BioMedical, Inc.. For the full company profile including market capitalisation, see Impact BioMedical, Inc. market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.43x | $-5.64 Million | $-5.64 Million | $13.05 Million | ▼ -149.5% |
| 2023 | -0.17x | $-2.83 Million | $-2.85 Million | $16.37 Million | ▲ +43.5% |
| 2022 | -0.31x | $-4.24 Million | $-4.33 Million | $13.83 Million | ▲ +89.2% |
| 2021 | -2.84x | $-2.97 Million | $-3.25 Million | $1.05 Million | ▼ -19272.8% |
| 2020 | -0.01x | $-1.14K | $-1.14K | $78.03K | ▲ +99.7% |
| 2019 | -5.54x | $-120.46K | $-121.98K | $21.72K | ▼ -54.7% |
| 2018 | -3.58x | $-71.99K | $-71.99K | $20.09K | ▲ +71.5% |
| 2017 | -12.59x | $-320.34K | $-320.34K | $25.44K | — |